Experienced in Progressive Osseous Heteroplasia

Dr. Todd A. Swanson

Radiation Oncology
13900 Katy Fwy, 
Houston, TX 
Accepting New Patients
Experienced in Progressive Osseous Heteroplasia
13900 Katy Fwy, 
Houston, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Todd Swanson is a Radiation Oncologist in Houston, Texas. Dr. Swanson is rated as an Experienced provider by MediFind in the treatment of Progressive Osseous Heteroplasia. His top areas of expertise are Posterior Fossa Tumor, Metastatic Brain Tumor, Primitive Neuroectodermal Tumor (PNET), and Astrocytoma. Dr. Swanson is currently accepting new patients in some locations.

His clinical research consists of co-authoring 33 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Radiation Oncology
Licenses
Radiology in MI
Hospital Affiliations
University Of Texas Medical Branch Galveston
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 2 Less Insurance Carriers -

Locations

MD Anderson
13900 Katy Fwy, Houston, TX 77079
Other Locations
MD Anderson
2130 W Holcombe Blvd, Univ Of Tx M D Ande Life, Houston, TX 77030
UTMB FACULTY GROUP PRACTICE
301 University Blvd, Galveston, TX 77555

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Randomized Phase III Trial of Hypofractionated Post-Prostatectomy Radiation Therapy (HYPORT) Versus Conventional Post-Prostatectomy Radiation Therapy (COPORT)
A Randomized Phase III Trial of Hypofractionated Post-Prostatectomy Radiation Therapy (HYPORT) Versus Conventional Post-Prostatectomy Radiation Therapy (COPORT)
Enrollment Status: Active_not_recruiting
Publish Date: October 03, 2025
Intervention Type: Other, Radiation
Study Phase: Phase 3
Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Other, Radiation, Drug
Study Drug: Temozolomide
Study Phase: Phase 2
A Randomized Phase III Trial of Memantine and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Patients With Brain Metastases
A Randomized Phase III Trial of Memantine and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Patients With Brain Metastases
Enrollment Status: Completed
Publish Date: April 23, 2025
Intervention Type: Radiation, Drug
Study Phase: Phase 3
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Enrollment Status: Active_not_recruiting
Publish Date: March 11, 2025
Intervention Type: Radiation, Drug
Study Drugs: Docetaxel, Gemcitabine, Pemetrexed Disodium, Erlotinib Hydrochloride, Pembrolizumab
Study Phase: Phase 2
Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma
Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma
Enrollment Status: Active_not_recruiting
Publish Date: August 02, 2024
Intervention Type: Drug, Radiation
Study Drugs: Concomitant Temozolomide (TMZ), Procarbazine, Adjuvant Temozolomide (TMZ), CCNU, Vincristine
Study Phase: Phase 3
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 17, 2024
Intervention Type: Radiation
Study Phase: Phase 2/Phase 3
Phase III Comparison of Thoracic Radiotherapy Regimens in Patients With Limited Small Cell Lung Cancer Also Receiving Cisplatin and Etoposide
Phase III Comparison of Thoracic Radiotherapy Regimens in Patients With Limited Small Cell Lung Cancer Also Receiving Cisplatin and Etoposide
Enrollment Status: Unknown
Publish Date: June 12, 2023
Intervention Type: Drug, Radiation
Study Drugs: Cisplatin, Etoposide, Carboplatin
Study Phase: Phase 3
View 6 Less Clinical Trials

32 Total Publications

Therapy, Safety, and Logistics of Preoperative vs Postoperative Stereotactic Radiation Therapy: A Preliminary Analysis of a Randomized Clinical Trial.
Therapy, Safety, and Logistics of Preoperative vs Postoperative Stereotactic Radiation Therapy: A Preliminary Analysis of a Randomized Clinical Trial.
Journal: JAMA oncology
Published: June 18, 2025
Similar Doctors
Experienced in Progressive Osseous Heteroplasia
Dr. Andrew M. Farach
Radiation Oncology
Experienced in Progressive Osseous Heteroplasia
Dr. Andrew M. Farach
Radiation Oncology

Tmh Physician Associates PLLC

7575 San Felipe St, Suite 155, 
Houston, TX 
 (8.0 miles away)
713-266-9955
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Andrew Farach is a Radiation Oncologist in Houston, Texas. Dr. Farach is rated as a Distinguished provider by MediFind in the treatment of Progressive Osseous Heteroplasia. His top areas of expertise are Lung Cancer, Endometrial Cancer, Pleuropulmonary Blastoma, Gamma Knife Radiosurgery, and Prostatectomy. Dr. Farach is currently accepting new patients.

Experienced in Progressive Osseous Heteroplasia
Dr. Ngoc T. Pham
Radiation Oncology
Experienced in Progressive Osseous Heteroplasia
Dr. Ngoc T. Pham
Radiation Oncology

Oncology Consultants, P.A.

10405 Katy Fwy, 
Houston, TX 
 (4.5 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Ngoc Pham is a Radiation Oncologist in Houston, Texas. Dr. Pham is rated as an Advanced provider by MediFind in the treatment of Progressive Osseous Heteroplasia. Her top areas of expertise are Anal Cancer, Breast Cancer, HER-2 Positive Breast Cancer, and Familial Prostate Cancer. Dr. Pham is currently accepting new patients.

Experienced in Progressive Osseous Heteroplasia
Dr. Ali Mazloom
Radiation Oncology
Experienced in Progressive Osseous Heteroplasia
Dr. Ali Mazloom
Radiation Oncology

Specialty Associates Of West Houston PLLC

21214 Northwest Fwy, 
Cypress, TX 
 (9.7 miles away)
832-912-3791
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Ali Mazloom is a Radiation Oncologist in Cypress, Texas. Dr. Mazloom is rated as an Advanced provider by MediFind in the treatment of Progressive Osseous Heteroplasia. His top areas of expertise are Breast Cancer, Angiosarcoma, Pleuropulmonary Blastoma, and Non-Muscle Invasive Bladder Cancer. Dr. Mazloom is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Swanson's expertise for a condition
ConditionClose
    View All 10 Distinguished Conditions
    View All 20 Advanced Conditions
    View All 36 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile